News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambrex Corporation (CBM) To Present At Rodman & Renshaw 16th Annual Global Investment Conference



9/3/2014 4:03:21 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EAST RUTHERFORD, N.J., Sept. 3, 2014 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven M. Klosk, President and Chief Executive Officer, will present at the Rodman and Renshaw 16th Annual Global Investment Conference on September 10, 2014 at 1:15 p.m. EDT in New York City.

The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under "Webcasts & Presentations", and a replay will be available for 90 days after the live event concludes.

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit http://www.cambrex.com/.

SOURCE Cambrex Corporation

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES